Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 6/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.47 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.47 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.47 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9516460 | 0.91 | ALDH1A1 (0.69) | LMNAALDH1A1SMN1; SMN2HPGDTSHR | |
| SCHEMBL19308752 | 0.87 | ALDH1A1 (0.59) | ALDH1A1SMN1; SMN2HPGDTSHRNPSR1 | |
| SCHEMBL19308746 | 0.87 | ALDH1A1 (0.59) | ALDH1A1SMN1; SMN2HPGDTSHRNPSR1 | |
| SCHEMBL10982270 | 0.81 | SMN1; SMN2 (0.60) | LMNAALDH1A1SMN1; SMN2HPGDTSHR | |
| SCHEMBL14873215 | 0.78 | NPSR1 (0.58) | LMNAALDH1A1SMN1; SMN2HPGDNPSR1 | |
| SCHEMBL13638135 | 0.78 | SMN1; SMN2 (0.56) | LMNAALDH1A1SMN1; SMN2HPGDTSHR | |
| SCHEMBL10587847 | 0.78 | ALDH1A1 (0.83) | LMNAALDH1A1SMN1; SMN2HPGDNPSR1 | |
| SCHEMBL6562134 | 0.78 | LMNA (1.00) | LMNAALDH1A1TSHRHDAC2KMT2A | |
| SCHEMBL4894134 | 0.75 | SMN1; SMN2 (0.57) | LMNAALDH1A1SMN1; SMN2HPGDTSHR | |
| SCHEMBL21261925 | 0.75 | ALDH1A1 (0.49) | LMNAALDH1A1SMN1; SMN2HPGDTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090281066-A1 | Treatment of proliferative disorders with amino-substituted (E)-2,6- dialkoxystyryl 4-substituted benzylsulfones | TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2009-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090281066-A1 | Treatment of proliferative disorders with amino-substituted (E)-2,6- dialkoxystyryl 4-substituted benzylsulfones | CCNY, CCND2, ETV6 | LMNA 1265/4885ALDH1A1 1156/4885SMN1; SMN2 3461/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.